Anagenics Ltd (ASX: AN1) Share Price and News
Price
$0.006
Movement
0.00 (0.0)
as at 20 Jun - Closed (20 mins delayed)
52 Week Range
$0.005 - $0.01
1 Year Return
-14.29%
Anagenics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
$0.006
Day Change
0.00 (0.0)
52 Week Range
$0.005 - $0.01
Yesterday's Close
$0.006
Today's Open
$0.006
Days Range
$0.006 - $0.006
Volume
226,000
Avg. Volume (1 month)
184,754
Turnover
$1,356
as at 20 Jun - Closed
Anagenics Ltd (ASX: AN1)
Latest News
No posts found.
AN1 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|
About Anagenics Ltd
Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.
AN1 Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
19 Jun 2025 | $0.01 | $0.00 | 0.00% | 13,605 | $0.01 | $0.01 | $0.01 |
16 Jun 2025 | $0.01 | $0.00 | 0.00% | 39,053 | $0.01 | $0.01 | $0.01 |
11 Jun 2025 | $0.01 | $0.00 | 0.00% | 225,025 | $0.01 | $0.01 | $0.01 |
10 Jun 2025 | $0.01 | $0.00 | 0.00% | 100,000 | $0.01 | $0.01 | $0.01 |
06 Jun 2025 | $0.01 | $0.00 | 0.00% | 93,877 | $0.01 | $0.01 | $0.01 |
04 Jun 2025 | $0.01 | $0.00 | 0.00% | 232,644 | $0.01 | $0.01 | $0.01 |
03 Jun 2025 | $0.01 | $0.00 | 0.00% | 100,000 | $0.01 | $0.01 | $0.01 |
02 Jun 2025 | $0.01 | $0.00 | 0.00% | 1,572,570 | $0.01 | $0.01 | $0.01 |
27 May 2025 | $0.01 | $0.00 | 0.00% | 1,335,203 | $0.01 | $0.01 | $0.01 |
26 May 2025 | $0.01 | $0.00 | 0.00% | 35,499 | $0.01 | $0.01 | $0.01 |
23 May 2025 | $0.01 | $0.00 | 0.00% | 71,429 | $0.01 | $0.01 | $0.01 |
22 May 2025 | $0.01 | $0.00 | 0.00% | 100,000 | $0.01 | $0.01 | $0.01 |
21 May 2025 | $0.01 | $0.00 | 0.00% | 100,000 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
16 May 2025 | Alexander (Sandy) Beard | Buy | 55,564 | $336 |
On-market trade.
|
14 May 2025 | Alexander (Sandy) Beard | Buy | 5 | $0 |
On-market trade.
|
12 May 2025 | Alexander (Sandy) Beard | Buy | 226,876 | $1,373 |
On-market trade.
|
08 May 2025 | Alexander (Sandy) Beard | Buy | 267,555 | $1,619 |
On-market trade.
|
07 May 2025 | Alexander (Sandy) Beard | Buy | 1,950,000 | $14,337 |
On-market trade.
|
06 May 2025 | Alexander (Sandy) Beard | Buy | 745,933 | $6,007 |
On-market trade.
|
05 May 2025 | Alexander (Sandy) Beard | Buy | 1,734,067 | $12,924 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Alexander (Sandy) Damien Harry Beard | Non-Executive ChairmanNon-Executive Director | Feb 2022 |
Mr Beard is a Company Director, Investor and Investment professional focussed on driving value from small cap ASX listed companies and private equity and early-stage investments.
|
Mr Phillip Christopher | Non-Executive Director | Nov 2021 |
Mr Christopher is Investment Director of Hancock and Gore Limited, responsible for advising and guiding private investments including BLC Cosmetics prior to its acquisition by Anagenics Limited. Phillip also spent 6 years at Alceon Group where he was a director in the private equity team which made investments in e-commerce and proprietary brand-based businesses. Prior to that he was a member of the investment banking division of Goldman Sachs.
|
Mr Scott Mitchell Greasley | Executive Director | Jul 2022 |
Mr Greasley has over 15 years of experience across retail, ecommerce and wholesale within the branded consumer segment. He has led teams transforming underperforming markets across APAC, Asia and the Middle East into highly profitable regions. Scott's offering is identifying and building consumer businesses that deliver EBITDA growth, with minimal investment. Scott has experience working in both private equity and ASX-listed environments.
|
Mr Hemant Amin | Company Secretary | Jun 2024 |
-
|
Hemant Amin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Hancock & Gore | 127,315,148 | 27.60% |
H&G High Conviction Limited | 57,504,542 | 12.47% |
Hancock and Gore Limited | 24,687,500 | 5.35% |
Dennis Eck | 19,196,581 | 4.16% |
Mango Tree Management Pty Ltd | 13,157,895 | 2.85% |
Mr Nicholas Dermott Mcdonald | 13,050,225 | 2.83% |
P & M Maguire Super Pty Ltd <P & M Maguire S/F A/C> | 8,800,000 | 1.91% |
Vivre Investments Pty Ltd | 7,800,000 | 1.69% |
Bungeeltap Pty Ltd | 6,000,000 | 1.30% |
Fordholm Consultants Pty Ltd <Diana Boehme Super Fund A/C> | 6,000,000 | 1.30% |
Maria Halasz | 5,047,305 | 1.09% |
Mr Phillip Thuaux | 4,794,989 | 1.04% |
Cannington Corporation Pty Limited <Cannington Super Fund A/C> | 4,550,000 | 0.99% |
Mr Antony Stephen Iles | 4,502,685 | 0.98% |
Dr Ida Constable | 3,740,637 | 0.81% |
Ubs Nominees Pty Ltd | 3,663,378 | 0.79% |
Mr Alexander Beard | 3,125,000 | 0.68% |
L X X X I X Pty Ltd | 3,016,675 | 0.65% |
Mr Hugh Alexander Robertson & Mrs Lisa Ann Scott <Hala Super Fund A/C> | 3,000,000 | 0.65% |
Ms Catherine Robertson & Ms Hannah Robertson <HCH Robertson S/F A/C> | 3,000,000 | 0.65% |